CopyMark Law Group
4.9/5
Drawing for D DAIICHI

USPTO serial 75331515

D DAIICHI

Reviewed by CopyMark Law Group

Reg. 2233521Status 710
Filing date
Status date
Registration date
Mar 23, 1999
Examiner
LEVINE, HOWARD B
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with D DAIICHI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebeccah Gan

Rebeccah Gan WENDEROTH, LIND & PONACK, L.L.P.1030 15th Street, NW Suite 400 EastWashington, DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[chemicals, namely, [ acrinol, ] D-calcium pantothenate, dexpanthenol, pantethine-A, [ disodium adenosine triphosphate, epsilon-aminocaproic acid, gamma-aminobutyric acid,] pyridoxal 5-phosphate, [ pyridoxine hydrochloride, ] sulfadimethoxine, [ sulfadimethoxine sodium, sulfamonomethoxine sodium, sulpyrine, ] tranexamic acid, [ sulfamonomethoxine, (P-hydroxyphenyl) propionic acid for use in the manufacture of pharmaceuticals, cosmetics and food additives ]]SECTION 8 - CANCELLED—
005[ * in * vitro diagnostic agents for medical use, diagnostic aids for in vitro biological tests, namely, reagent strips for urine and blood tests, central nervous system depressants, ophthalmic use agents, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactics for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital andrenal hyperplasia, rheumatoid arthritis, rheumatic fever, Crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago, stiffness and for the treatment of the shoulder; hair remedies, vitamin preparations, namely, dietary supplements, food enriching agents for treating vitamin deficiencies, anticoagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, ] antibiotics and their preparations for the treatment of infectious diseases, [ antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelminitics for the treatment of threadworm and for the treatment of toxoplasmosis, excipients, namely, tablet coating polymers soluble in gastric tract, naturally occuring drugs and charred drugs and moxa for the treatment of peptic ulcers, veterinary drugs for the treatment of distemper in dogs, veterinary drugs for the treatment of distomatosis in dogs, veterinary drugs for the treatment of coccidium in chickens, veterinary drugs for the treatment of dysentery in pigs; insecticides for agricultural and/or domestic use, rodenticides for agricultural and/or domestic use, herbicides for agricultural and/or domestic use; antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment of cancer, multienzyme digestants, antifungal antibiotics for the treatment of trichomoniasis and dermatophytosis, anti-parkinsonism agents, minor tranquillizing agents, and antianxiety agents ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 25, 2019CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Mar 23, 2018REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Aug 12, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 12, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 13, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 8, 2009RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Apr 8, 20099G8PREGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8—
Apr 8, 20098PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
Mar 27, 2009PLGLASSIGNED TO PARALEGAL—
Mar 20, 200989AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Mar 20, 2009MAILPAPER RECEIVED—
Sep 19, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 19, 2007CFITCASE FILE IN TICRS—
Dec 20, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 12, 2006AMD7SEC 7 REQUEST FILED—
Jan 12, 2006MAILPAPER RECEIVED—
Dec 21, 2005C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 21, 2005PLGLASSIGNED TO PARALEGAL—
Jul 18, 2005MAILPAPER RECEIVED—
Jul 14, 2005815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Jul 14, 2005E815TEAS SECTION 8 & 15 RECEIVED—
Feb 28, 2000COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jan 19, 2000AMD7SEC 7 REQUEST FILED—
Jul 19, 1999AMD7SEC 7 REQUEST FILED—
Mar 23, 1999R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 29, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 1998NPUBNOTICE OF PUBLICATION—
Oct 14, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 1998CNEAEXAMINER'S AMENDMENT MAILED—
Sep 22, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance